|1.||Van den Berghe, Greet: 42 articles (10/2015 - 09/2002)|
|2.||Vanhorebeek, Ilse: 21 articles (10/2015 - 01/2005)|
|3.||Zhang, Wei: 17 articles (12/2015 - 01/2006)|
|4.||Scheen, A J: 17 articles (02/2014 - 03/2000)|
|5.||Horowitz, Michael: 16 articles (06/2015 - 10/2003)|
|6.||Liu, Yan: 15 articles (11/2015 - 04/2004)|
|7.||Preiser, Jean-Charles: 15 articles (09/2015 - 09/2002)|
|8.||Zhang, Yu: 15 articles (05/2015 - 06/2005)|
|9.||Umpierrez, Guillermo E: 15 articles (03/2015 - 03/2002)|
|10.||Wouters, Pieter J: 15 articles (05/2014 - 02/2003)|
|1.||Body Weight (Weight, Body)
10/01/1995 - "Nineteen of these products were effective, when administered at an oral dose of 100 mg/kg body weight in inducing a marked reduction in blood glucose level."
05/01/2012 - "This study has shown that a 10-week intervention to promote physical activity was effective in significantly decreasing the population's BP by 1.56 / 0.74 mm Hg, fasting blood sugar levels by 2.82 mg%, body weight by 0.17 kg, and BMI by 0.06 kg / m(2). "
07/22/1994 - "In this study feeding diabetic rats and rabbits with 0.39 g/kg body weight of the aqueous extract of the aerial parts of the plant for 2-4 weeks shows a significant reduction in blood glucose level, prevents elevation of glycosylated haemoglobin level and possesses a hypoliposis effect, in addition to the protection against body weight loss of diabetic animals."
08/01/2015 - "There was significant reduction in fasting blood sugar (P=0.001), body weight (P=0.001), BMI (P=0.001), waist circumference (P=0.001) and blood pressure (P=0.001). "
09/01/2014 - "A significant reduction in blood glucose level along with an increase in body weight was observed in diabetic rats treated with D. "
10/29/2004 - "Overexpression of dominant-negative type JNK in the liver of obese diabetic mice dramatically improved insulin resistance and markedly decreased blood glucose levels. "
01/01/2015 - "Injection of nesfatin-1 after SG significantly improved insulin resistance and reduced blood glucose levels. "
08/14/2014 - "After 28 weeks of treatment, the levels of fasting blood sugar and insulin resistance improved significantly in the G1 group (P< 0·001). "
01/01/2013 - "In subjects with type 2 diabetes, this surgical intervention results in a significant reduction in blood glucose and insulin resistance."
08/01/2005 - "Blood glucose (204+/-16 mg/dL to 147+/-8 mg/dL, P<.001) and insulin resistance (9.11+/-1.51 to 7.15+/-1.15, P=.04) improved significantly in the ST group, whereas no significant changes were observed in the ET group. "
|3.||Hypoglycemia (Reactive Hypoglycemia)
01/01/2004 - "Newer insulins and easier blood glucose monitoring have greatly improved the ability to obtain excellent control of blood glucose levels with less risk of hypoglycemia. "
01/01/2008 - "To date, clinical trials in children and adolescents have been few in number, but the evidence available from these and from other studies carried out in adults with type 1 diabetes suggest that they offer significant benefits in terms of reduced frequency of nocturnal hypoglycemia, better postprandial blood glucose control, and improved quality of life when compared with traditional insulins. "
10/09/2012 - "GA may also reflect the status of blood glucose more rapidly (2-3 weeks) than HbA1c (2-3 months), and is beneficial in those with wide variations in blood glucose or at higher risk for hypoglycemia. "
11/01/2009 - "Although glycemic control was significantly improved, the patient safety risk from hypoglycemia did not increase, as rates of blood glucose <50 mg/dL decreased from 0.68% at baseline to 0.64% in 2007."
10/01/2009 - "Significant differences were observed with respect to HbA(1c) (P<0.05), well-being (P<0.05), diabetes-related distress (P<0.01), frequency of blood glucose testing (P<0.05), avoidance of hypoglycemia (P<0.01), perceived stress (P<0.05), anxiety (P<0.05) and depression (P<0.05), all of which showed greater improvement in the intervention group compared with the control group. "
|4.||Type 2 Diabetes Mellitus (MODY)
01/01/2012 - "In addition to the lipid-lowering effect of bile acid sequestrants (BASs), they also lower blood glucose and, therefore, could be beneficial in the treatment of patients with type 2 diabetes mellitus (T2DM). "
01/01/2000 - "A multicentric study by the Indian Council of Medical Research showed that a preparation from Pterocarpus marsupium was effective in reducing levels of blood glucose and glycosylated haemoglobin in patients with non-insulin-dependent diabetes mellitus. "
05/20/2006 - "The efficacy of self-measurement of capillary blood glucose (SMBG) in patients with type 2 diabetes mellitus is not fully established. "
01/01/2011 - "A brief review of results of prospective randomized studies on the efficacy of reduction of blood glucose levels for the prevention of type 2 diabetes mellitus complications delivered at the 68th Congress of American Diabetic Association (June 2008). "
04/01/2006 - "The randomized clinical trials performed to date provided positive results on the effectiveness of interventions with self-monitoring of blood glucose in type 2 diabetes mellitus. "
07/01/2012 - "There was also statistically significant reduction in the fasting blood sugar (FBS) and post prandial blood sugar (PPBS) parameters, both in newly detected cases as well as chronic cases of type-2 diabetes mellitus."
10/31/2007 - "Dietary mulberry DNJ may be beneficial for the suppression of abnormally high blood glucose levels, thereby preventing diabetes mellitus. "
10/01/1998 - "In children with diabetes mellitus a significant reduction in attention was found at mild hypoglycaemia but as well at low normal blood glucose levels. "
08/01/1993 - "Thus, platelet hyperaggregation was present even at the time of diagnosis in patients with diabetes mellitus in the absence of any vascular complications, and there was significant improvement in platelet hyperaggregation after metabolic control of blood glucose levels was achieved."
01/01/2002 - "Using non-invasive techniques, measurements of the blood sugar level could be done more frequently and hence diagnosis as well as therapy of type II Diabetes Mellitus can be improved especially for this group of senior patients. "
|7.||Glycosylated Hemoglobin A (Glycosylated Hemoglobin)
|4.||Transplantation (Transplant Recipients)
|5.||Drug Therapy (Chemotherapy)